FDA announces voluntary recall of Sandoz ranitidine capsules following detection of an impurity - FDA Press Releases

The U.S. Food and Drug Administration is alerting health care professionals and patients of a voluntary recall of 14 lots of prescription ranitidine capsules distributed by Sandoz Inc.

from FDA Press Releases RSS Feed https://ift.tt/2mrLCWk
via IFTTT